- Home
- YSXT vs CABA Comparison
YSXT vs CABA Comparison
Compare YSXT & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- CABA
- Stock Information
- Founded
- YSXT 2011
- CABA 2017
- Country
- YSXT China
- CABA United States
- Employees
- YSXT N/A
- CABA N/A
- Industry
- YSXT Automotive Aftermarket
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YSXT Consumer Discretionary
- CABA Health Care
- Exchange
- YSXT Nasdaq
- CABA Nasdaq
- Market Cap
- YSXT 125.2M
- CABA 149.3M
- IPO Year
- YSXT 2024
- CABA 2019
- Fundamental
- Price
- YSXT $2.50
- CABA $1.62
- Analyst Decision
- YSXT
- CABA Strong Buy
- Analyst Count
- YSXT 0
- CABA 7
- Target Price
- YSXT N/A
- CABA $14.29
- AVG Volume (30 Days)
- YSXT 570.7K
- CABA 1.3M
- Earning Date
- YSXT 07-31-2025
- CABA 08-07-2025
- Dividend Yield
- YSXT N/A
- CABA N/A
- EPS Growth
- YSXT N/A
- CABA N/A
- EPS
- YSXT 0.18
- CABA N/A
- Revenue
- YSXT $71,452,736.00
- CABA N/A
- Revenue This Year
- YSXT N/A
- CABA N/A
- Revenue Next Year
- YSXT N/A
- CABA N/A
- P/E Ratio
- YSXT $13.54
- CABA N/A
- Revenue Growth
- YSXT 22.04
- CABA N/A
- 52 Week Low
- YSXT $1.68
- CABA $0.99
- 52 Week High
- YSXT $9.96
- CABA $6.26
- Technical
- Relative Strength Index (RSI)
- YSXT 37.96
- CABA 51.47
- Support Level
- YSXT $1.88
- CABA $1.54
- Resistance Level
- YSXT $2.78
- CABA $1.83
- Average True Range (ATR)
- YSXT 0.47
- CABA 0.13
- MACD
- YSXT 0.09
- CABA 0.02
- Stochastic Oscillator
- YSXT 49.70
- CABA 63.16
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.